CPMC-R.K. DAVIES MEDICAL CENTER
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $7.6M
- Transactions
- 793
- Companies
- 40
- Average per transaction
- $9,536
Who reported the payments
| Lilly USA, LLC | $1,115,920 |
| Edwards Lifesciences | $994,933 |
| Abbott | $990,118 |
| E.r. Squibb & Sons, L.L.C. | $522,803 |
| Novartis | $498,434 |
| Boston Scientific | $497,634 |
| Gilead | $369,646 |
| Biogen | $352,594 |
| Eli Lilly | $297,533 |
| Alnylam Pharmaceuticals Inc. | $296,395 |
| Sanofi | $259,214 |
| AbbVie | $188,524 |
| Genentech, Inc. | $157,504 |
| Angiodynamics, Inc. | $154,500 |
| UCB SA | $126,569 |
| Sanofi Pasteur Inc. | $80,500 |
| Exelixis Inc. | $61,105 |
| Stryker | $54,667 |
| AstraZeneca | $54,244 |
| Tesaro, Inc. | $41,583 |
| Incyte Corporation | $41,300 |
| Iovance Biotherapeutics, Inc. | $38,980 |
| Modernatx, Inc. | $37,972 |
| Astrazeneca UK Limited | $37,008 |
| Jenavalve Technology, Inc. | $34,337 |
| Eisai Inc. | $29,141 |
| Bristol Myers Squibb | $25,625 |
| Acerta Pharma LLC | $24,235 |
| Morphosys AG | $23,056 |
| Enterra Medical, Inc. | $20,396 |
| Orion Corporation | $15,041 |
| Clovis Oncology, Inc. | $13,634 |
| Argenx US, Inc. | $13,344 |
| GT Medical Technologies, Inc | $12,947 |
| Atricure, Inc. | $10,540 |
| Amgen | $10,500 |
| GE HealthCare | $9,950 |
| KARL Storz Endoscopy-america | $8,708 |
| Halozyme Inc | $7,981 |
| Siemens Medical Solutions USA, Inc. | $4,910 |